Ad is loading...
PEMGX
Price
$46.75
Change
+$0.66 (+1.43%)
Updated
Nov 22 closing price
PGRRX
Price
$50.44
Change
+$0.68 (+1.37%)
Updated
Nov 22 closing price
Ad is loading...

PEMGX vs PGRRX

Header iconPEMGX vs PGRRX Comparison
Open Charts PEMGX vs PGRRXBanner chart's image
Principal MidCap A
Price$46.75
Change+$0.66 (+1.43%)
VolumeN/A
CapitalizationN/A
Pioneer Select Mid Cap Growth R
Price$50.44
Change+$0.68 (+1.37%)
VolumeN/A
CapitalizationN/A
PEMGX vs PGRRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PEMGX vs. PGRRX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEMGX is a Buy and PGRRX is a Buy.

FUNDAMENTALS
Fundamentals
PEMGX has more cash in the bank: 29.9B vs. PGRRX (1.59B). PEMGX (0.00) and PGRRX (0.00) have matching dividends . PEMGX was incepted earlier than PGRRX: PEMGX (19 years) vs PGRRX (31 years). PGRRX is a more actively managed with annual turnover of: 72.00 vs. PEMGX (10.10). PGRRX has a lower initial minimum investment than PEMGX: PGRRX (0) vs PEMGX (1000). PGRRX annual gain was more profitable for investors over the last year : 41.37 vs. PEMGX (29.83). PEMGX return over 5 years is better than : 51.07 vs. PGRRX (19.58).
PEMGXPGRRXPEMGX / PGRRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years31 years-
Gain YTD25.51730.10185%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets29.9B1.59B1,885%
Annual Yield % from dividends0.000.00-
Returns for 1 year29.8341.3772%
Returns for 3 years6.94-9.77-71%
Returns for 5 years51.0719.58261%
Returns for 10 years104.4239.38265%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CORT57.541.62
+2.90%
Corcept Therapeutics
XPEL45.730.88
+1.96%
XPEL
MCO480.663.59
+0.75%
Moody's Corp
ORGO4.050.03
+0.75%
Organogenesis Holdings
ELTX4.93-0.19
-3.71%
Elicio Therapeutics